Close Menu

NEW YORK (360Dx) — The US Army has awarded Abbott Laboratories a contract for more than $35.2 million to develop a traumatic brain injury diagnostic assay.

The US Department of Defense said last week that work on the assay will be performed in Abbott Park, Illinois with an estimated completion date of Aug. 31, 2022. Fiscal 2019 research, development, test, and evaluation funds of $12 million were obligated at the time of the award, DoD said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.